More importantly, the study for the first time proved that CARM1 inhibitor treatment significantly inhibits GC tumour growth both in vitro and in vivo, and synergises with autophagy inhibitors, presenting a promising therapeutic strategy [91]. The gene discussed is CARM1; the disease is gastric cancer.